<  Back to the Polytechnique Montréal portal

Dexrazoxane Treatments Limits Subclinical Cardiac Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors Exposed to Doxorubicin Treatments

Marc-Olivier Lapointe, Maxime Caru, Daniel Curnier, Marie-Josée Raboisson, Grégor Andelfinger, Maja Krajinović, Caroline Laverdière, Daniel Sinnett and Delphine Périé-Curnier

Article (2022)

An external link is available for this item
Department: Department of Mechanical Engineering
PolyPublie URL: https://publications.polymtl.ca/70763/
Journal Title: Journal of Pediatric Hematology/Oncology (vol. 45, no. 2)
Publisher: Lippincott Williams & Wilkins
DOI: 10.1097/mph.0000000000002538
Official URL: https://doi.org/10.1097/mph.0000000000002538
Date Deposited: 22 Dec 2025 14:30
Last Modified: 22 Dec 2025 14:30
Cite in APA 7: Lapointe, M.-O., Caru, M., Curnier, D., Raboisson, M.-J., Andelfinger, G., Krajinović, M., Laverdière, C., Sinnett, D., & Périé-Curnier, D. (2022). Dexrazoxane Treatments Limits Subclinical Cardiac Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors Exposed to Doxorubicin Treatments. Journal of Pediatric Hematology/Oncology, 45(2), 70-77. https://doi.org/10.1097/mph.0000000000002538

Statistics

Dimensions

Repository Staff Only

View Item View Item